We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
LSE:0RA9
​
​
logo

ABIVAX Société Anonyme (0RA9)

LSE • 0RA9 • FR0012333284

80.75Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 21, 2026, ORTEX estimated 2.4% of free float sold short, 234.6 days to cover, cost to borrow 1.45%. Sign up for live short interest data.

Market Cap

7.76b USD | # 1096 in GB

Volume

4.17k shares | 13.44m USD

Shares Outstanding

87.18m

Free Float Shares

98.87% | 86.19m

Nasdaq:ABVX|
OTCPK:AAVX.F|
DB:2X1|
DB:2X10|
XTRA:2X1|
ENXTPA:ABVX|
WBAG:ABVX

News

0RA9 key data

ABIVAX Société Anonyme (LSE: 0RA9) has a market capitalization of $7.76B. Last close €80.75 (as of 2026-11-05); 52-week range €60.70 to €139.00. ORTEX data as of 2026-10-21: short interest was 2.39% of free float, 234.6 days to cover and the average cost to borrow was 1.45%. Sign up for live short interest data.

  • 0RA9 news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.